Related references
Note: Only part of the references are listed.Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
Beatriz Tejera Segura et al.
RHEUMATOLOGY (2020)
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Martin Aringer et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity
Manman Liu et al.
CLINICAL RHEUMATOLOGY (2018)
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus
Jyotsna Bhattacharya et al.
MOLECULAR MEDICINE (2018)
Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus
Thierry Dervieux et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features
Melissa E. Munroe et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Role of interferons in SLE
Anders A. Bengtsson et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
Melissa E. Munroe et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
Rufei Lu et al.
JOURNAL OF AUTOIMMUNITY (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
We Need Better Classification and Terminology for People at High Risk of or in the Process of Developing Lupus
Karen H. Costenbader et al.
ARTHRITIS CARE & RESEARCH (2015)
Distinctions Between Diagnostic and Classification Criteria?
Rohit Aggarwal et al.
ARTHRITIS CARE & RESEARCH (2015)
Development of SLE among potential SLE patients seen in consultation: long-term follow-up
M. Al Daabil et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus
C. Eriksson et al.
LUPUS (2014)
Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures
Laurent Chiche et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
Chaim Putterman et al.
LUPUS SCIENCE & MEDICINE (2014)
Measurement of Cell-Bound Complement Activation Products Enhances Diagnostic Performance in Systemic Lupus Erythematosus
Kenneth C. Kalunian et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
IgG and IgM Autoantibody Differences in Discoid and Systemic Lupus Patients
Benjamin F. Chong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Autoantibody profiling to follow evolution of lupus syndromes
Nancy J. Olsen et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Network Analysis of Associations Between Serum Interferon-α Activity, Autoantibodies, and Clinical Features in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2011)
Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden
Catharina Eriksson et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes
Q. -Z. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Excessive production of IFN-γ in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B
Masayoshi Harigai et al.
JOURNAL OF IMMUNOLOGY (2008)
IgM antibodies against dsDNA in SLE
Torsten Witte
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes
Q. -Z. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus
J. A. James et al.
LUPUS (2007)
Type I interferon correlates with serological and clinical manifestations of SLE
MC Dall'Era et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse
S Werwitzke et al.
ARTHRITIS AND RHEUMATISM (2005)
Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus
S Manzi et al.
ARTHRITIS AND RHEUMATISM (2004)
Outcome of incomplete systemic lupus erythematosus after 10 years
CS Hallengren et al.
LUPUS (2004)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT)
AJG Swaak et al.
RHEUMATOLOGY (2001)
Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus
LM Vila et al.
LUPUS (2000)
Share Paper
